ActiveCare Adds Over 2,400 New Members in the Quarter Ended September 30, 2014


OREM, Utah, Oct. 9, 2014 (GLOBE NEWSWIRE) -- ActiveCare Inc. (OTCBB:ACAR), a leader in diabetes monitoring and wellness services for self-insured employers nationwide, added 2,438 new members between July 1, 2014 and September 30, 2014.

"We are excited that our strategic plan of increasing our sales resources and its resulting effectiveness has lead to strong membership growth," commented Michael Z. Jones, CEO of ActiveCare. "This is the greatest quarterly growth in our membership in the last 18 months. With this progress we are on target to surpass $11 million in revenue over the next 12 months."

Over the past six months ActiveCare has expanded its sales and marketing resources enabling more effective closure of strategic opportunities. This refocus has resulted in substantial growth of membership for the most recent quarter as well as significantly increasing the pipeline for future business.

About ActiveCare

ActiveCare, Inc. provides patented diabetes monitoring and wellness solutions that increase visibility, lower costs and provide real-time care for members resulting in improved outcomes. Utilizing state-of-the-art meters with embedded cellular technology, trained CareSpecialists can intervene in real-time and provide members with the support needed to control their disease 24 hours a day, every day. Headquartered in Orem, Utah and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare's solution is revolutionizing the way employers, individuals and their health plans monitor chronic disease. To learn more about ActiveCare, Inc., visit the website at www.activecare.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, regulatory uncertainty and economic pressure on the healthcare industry in particular, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with assimilating our recent acquisitions. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.


            

Contact Data